Skip to main content
SpringerLink
Log in

Assessment of islet function following islet and pancreas transplantation

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Pancreas and islet transplant recipients are monitored using various metabolic and imaging methods. The inaccessibility of the transplanted whole pancreas and of the isolated islets poses specific problems (eg, all assessment techniques are indirect). Although successful pancreas transplantation typically restores normal glucose homeostasis, islet transplantation into the liver does not completely normalize islet hormone secretion and glucose metabolism. Development of better testing strategies, such as direct islet imaging, will significantly advance the field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Gruessner AC, Sutherland DE: Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005, 19:433–455.

    Article  PubMed  Google Scholar 

  2. Sutherland DE, Gruessner RW, Dunn DL, et al.: Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001, 233:463–501.

    Article  PubMed  CAS  Google Scholar 

  3. Robertson RP, Davis C, Larsen J, et al.: Pancreas transplantation for patients with type 1 diabetes. Diabetes Care 2003, 26(suppl 1):S120.

    PubMed  Google Scholar 

  4. Landgraf R: Impact of pancreas transplantation on diabetic secondary complications and quality of life. Diabetologia 1996, 39:1415–1424.

    Article  PubMed  CAS  Google Scholar 

  5. Venstrom JM, McBride MA, Rother KI, et al.: Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003, 290:2817–2823.

    Article  PubMed  CAS  Google Scholar 

  6. Joist H, Brennan DC, Coyne DW: Anemia in the kidneytransplant patient. Adv Chronic Kidney Dis 2006, 13:4–10.

    Article  PubMed  Google Scholar 

  7. Boratynska M, Banasik M, Watorek E, et al.: Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients. Transplant Proc 2006, 38:101–104.

    Article  PubMed  CAS  Google Scholar 

  8. Williams D, Haragsim L: Calcineurin nephrotoxicity. Adv Chronic Kidney Dis 2006, 13:47–55.

    Article  PubMed  Google Scholar 

  9. Najarian JS, Sutherland DE, Matas AJ, et al.: Human islet transplantation: a preliminary report. Transplant Proc 1977, 9:233–236.

    PubMed  CAS  Google Scholar 

  10. Largiader F, Kolb E, Binswanger U: A long-term functioning human pancreatic islet allotransplant. Transplantation 1980, 29:76–77.

    Article  PubMed  CAS  Google Scholar 

  11. Scharp DW, Lacy PE, Santiago JV, et al.: Insulin independence after islet transplantation into type I diabetic patient. Diabetes 1990, 39:515–518.

    Article  PubMed  CAS  Google Scholar 

  12. Ricordi C, Lacy PE, Finke EH, et al.: Automated method for isolation of human pancreatic islets. Diabetes 1988, 37:413–420.

    Article  PubMed  CAS  Google Scholar 

  13. Shapiro AM, Lakey JR, Ryan EA, et al.: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000, 343:230–238.

    Article  PubMed  CAS  Google Scholar 

  14. Hirshberg B, Rother KI, Digon BJ III, et al.: Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience. Diabetes Care 2003, 26:3288–3295.

    Article  PubMed  Google Scholar 

  15. Rother KI, Harlan DM: Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest 2004, 114:877–883. Perspective of progress as well as remaining challenges in the field of islet cell transplantation and replacement..

    Article  PubMed  CAS  Google Scholar 

  16. Luzi L, Hering BJ, Socci C, et al.: Metabolic effects of successful intraportal islet transplantation in insulindependent diabetes mellitus. J Clin Invest 1996, 97:2611–2618.

    PubMed  CAS  Google Scholar 

  17. Diem P, Redmon JB, Abid M, et al.: Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. J Clin Invest 1990, 86:2008–2013.

    Article  PubMed  CAS  Google Scholar 

  18. Ryan EA, Lakey JR, Paty BW, et al.: Successful islet transplantation: continued insulin reserve provides longterm glycemic control. Diabetes 2002, 51:2148–2157. Excellent overview of the first 3 years after islet transplantation..

    Article  PubMed  CAS  Google Scholar 

  19. Ryan EA, Paty BW, Senior PA, et al.: Five-year followup after clinical islet transplantation. Diabetes 2005, 54:2060–2069.

    Article  PubMed  CAS  Google Scholar 

  20. Evgenov NV, Medarova Z, Dai G, et al.: In vivo imaging of islet transplantation. Nat Med 2006, 12:144–148.

    Article  PubMed  CAS  Google Scholar 

  21. Paty BW, Bonner-Weir S, Laughlin MR, et al.: Toward development of imaging modalities for islets after transplantation: insights from the National Institutes of Health Workshop on Beta Cell Imaging. Transplantation 2004, 77:1133–1137.

    Article  PubMed  Google Scholar 

  22. Christiansen E, Kjems LL, Volund A, et al.: Insulin secretion rates estimated by two mathematical methods in pancreas-kidney transplant recipients. Am J Physiol 1998, 274(4 Pt 1):E716-E725.

    PubMed  CAS  Google Scholar 

  23. Sutherland DE, Gruessner A, Hering BJ: Beta-cell replacement therapy (pancreas and islet transplantation) for treatment of diabetes mellitus: an integrated approach. Endocrinol Metab Clin North Am 2004, 33:135–148, x.

    Article  PubMed  Google Scholar 

  24. Robertson RP, Sutherland DE, Kendall DM, et al.: Metabolic characterization of long-term successful pancreas transplants in type I diabetes. J Investig Med 1996, 44:549–555.

    PubMed  CAS  Google Scholar 

  25. Bhargava R, Senior PA, Ackerman TE, et al.: Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes 2004, 53:1311–1317.

    Article  PubMed  CAS  Google Scholar 

  26. Eckhard M, Lommel D, Hackstein N, et al.: Disseminated periportal fatty degeneration after allogeneic intraportal islet transplantation in a patient with type 1 diabetes mellitus: a case report. Transplant Proc 2004, 36:1111–1116.

    Article  PubMed  CAS  Google Scholar 

  27. Maffi P, Angeli E, Bertuzzi F, et al.: Minimal focal steatosis of liver after islet transplantation in humans: a long-term study. Cell Transplant 2005, 14:727–733.

    PubMed  Google Scholar 

  28. Markmann JF, Rosen M, Siegelman ES, et al.: Magnetic resonance-de.ned periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival? Diabetes 2003, 52:1591–1594.

    Article  PubMed  CAS  Google Scholar 

  29. Toso C, Zaidi H, Morel P, et al.: Positron-emission tomography imaging of early events after transplantation of islets of Langerhans. Transplantation 2005, 79:353–355.

    Article  PubMed  Google Scholar 

  30. Ricordi C, Tzakis AG, Carroll PB, et al.: Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation 1992, 53:407–414.

    Article  PubMed  CAS  Google Scholar 

  31. Oberholzer J, Triponez F, Mage R, et al.: Human islet transplantation: lessons from13 autologous and 13 allogeneic transplantations. Transplantation 2000, 69:1115–1123.

    Article  PubMed  CAS  Google Scholar 

  32. Luzi L, Perseghin G, Brendel MD, et al.: Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients. Diabetes 2001, 50:277–282.

    Article  PubMed  CAS  Google Scholar 

  33. Rickels MR, Schutta MH, Markmann JF, et al.: Beta-cell function following human islet transplantation for type 1 diabetes. Diabetes 2005, 54:100–106. Evaluation of multiple islet hormones in addition to insulin in islet transplant patients.

    Article  PubMed  CAS  Google Scholar 

  34. Blackman JD, Polonsky KS, Jaspan JB, et al.: Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation. Diabetes 1992, 41:1346–1354.

    Article  PubMed  CAS  Google Scholar 

  35. Robertson RP, Sutherland DE, Lanz KJ: Normoglycemia and preserved insulin secretory reserve in diabetic patients 10-18 years after pancreas transplantation. Diabetes 1999, 48:1737–1740.

    Article  PubMed  CAS  Google Scholar 

  36. Kaufman DB, Leventhal JR, Gallon LG, et al.: Technical and immunologic progress in simultaneous pancreas-kidney transplantation. Surgery 2002, 132:545–553.

    Article  PubMed  Google Scholar 

  37. Dieterle CD, Schmauss S, Veitenhansl M, et al.: Glucose metabolism after pancreas transplantation: cyclosporine versus tacrolimus. Transplantation 2004, 77:1561–1565.

    Article  PubMed  CAS  Google Scholar 

  38. Dupre J, Curtis JD, Unger RH, et al.: Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man. J Clin Invest 1969, 48:745–757.

    PubMed  CAS  Google Scholar 

  39. Samols E, Marri G, Marks V: Promotion of insulin secretion by glucagon. Lancet 1965, 40:415–416.

    Article  Google Scholar 

  40. Alejandro R, Lehmann R, Ricordi C, et al.: Long-term function (6 years) of islet allografts in type 1 diabetes. Diabetes 1997, 46:1983–1989.

    Article  PubMed  CAS  Google Scholar 

  41. Service FJ, Molnar GD, Rosevear JW, et al.: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970, 19:644–655.

    PubMed  CAS  Google Scholar 

  42. Matsumoto S, Yamada Y, Okitsu T, et al.: Simple evaluation of engraftment by secretory unit of islet transplant objects for living donor and cadaveric donor fresh or cultured islet transplantation. Transplant Proc 2005, 37:3435–3437.

    Article  PubMed  CAS  Google Scholar 

  43. Ryan EA, Paty BW, Senior PA, et al.: Beta-score: an assessment of beta-cell function after islet transplantation. Diabetes Care 2005, 28:343–347.

    Article  PubMed  Google Scholar 

  44. Paty BW, Ryan EA, Shapiro AM, et al.: Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes 2002, 51:3428–3434.

    Article  PubMed  CAS  Google Scholar 

  45. Gupta V, Wahoff DC, Rooney DP, et al.: The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined. Diabetes 1997, 46:28–33.

    Article  PubMed  CAS  Google Scholar 

  46. Hirshberg B, Mog S, Patterson N, et al.: Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using Edmonton protocol immunosuppression. J Clin Endocrinol Metab 2002, 87:5424–5429.

    Article  PubMed  CAS  Google Scholar 

  47. Fowler M, Virostko J, Chen Z, et al.: Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging. Transplantation 2005, 79:768–776.

    Article  PubMed  Google Scholar 

  48. Dombrowski F, Mathieu C, Evert M: Hepatocellular neoplasms induced by low-number pancreatic islet transplants in autoimmune diabetic BB/Pfd rats. Cancer Res 2006, 66:1833–1843.

    Article  PubMed  CAS  Google Scholar 

  49. Ichii H, Inverardi L, Pileggi A, et al.: A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant 2005, 5:1635–1645.

    Article  PubMed  Google Scholar 

  50. Latif ZA, Noel J, Alejandro R: A simple method of staining fresh and cultured islets. Transplantation 1988, 45:827–830.

    Article  PubMed  CAS  Google Scholar 

  51. Sabek OM, Marshall DR, Minoru O, et al.: OP-142 gene expression profiles of nonfunctional human pancreatic islets: predictors of transplant failure? Transplant Proc 2005, 37:3441–3443

    Article  PubMed  CAS  Google Scholar 

  52. Sweet IR, Khalil G, Wallen AR, et al.: Continuous measurement of oxygen consumption by pancreatic islets. Diabetes Technol Ther 2002, 4:661–672.

    Article  PubMed  Google Scholar 

  53. Teuscher AU, Kendall DM, Smets YF, et al.: Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes 1998, 47:324–330.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetes Branch, National Institutes of Diabetes, and Digestive and Kidney Diseases, National Institutes of Health, 10 Center Drive, Building 10/ CRC, Room 5W-5942, 20892, Bethesda, MD, USA

    Kristina I. Rother MD

Authors
  1. Emily C. Dy BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David M. Harlan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kristina I. Rother MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kristina I. Rother MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dy, E.C., Harlan, D.M. & Rother, K.I. Assessment of islet function following islet and pancreas transplantation. Curr Diab Rep 6, 316–322 (2006). https://doi.org/10.1007/s11892-006-0067-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-006-0067-y

Keywords

Search

Navigation